Loading interactive chart...
1DInterval:
Date Range
1 min
Advertisement
U.S. markets closed
S&P Futures
5,078.75 -28.75 (-0.56%) Dow Futures
38,619.00 -61.00 (-0.16%) Nasdaq Futures
17,479.25 -185.25 (-1.05%) Russell 2000 Futures
2,012.00 +5.20 (+0.26%) Crude Oil
82.65 -0.16 (-0.19%) Gold
2,332.00 -6.40 (-0.27%)
Gabather AB (5J2.MU)
Munich - Munich Delayed Price. Currency in EUR
Follow
At close: 08:12AM CEST
Mountain
Settings
- PR Newswire
Gabather reports initial positive results from the EEG/fMRI target engagement study
Gabather AB (Nasdaq First North Growth Market: GABA) today reports initial positive results from the EEG/fMRI target engagement study, a double-blinded placebo-controlled, cross-over phase Ib study of Gabather's GABAA-receptor positive allosteric modulator, GT-002, in healthy volunteers.
Advertisement
Advertisement
Advertisement